If a rectal (or perirectal) swab is positive for carbapenem‑resistant Enterobacteriaceae (CRE), can we reasonably presume that the patient has CRE sepsis?

No—A Positive Rectal Swab for CRE Indicates Colonization, Not Sepsis

A positive rectal or perirectal swab for carbapenem-resistant Enterobacteriaceae (CRE) indicates gastrointestinal colonization, not active infection or sepsis. The CDC/HICPAC guidelines explicitly distinguish between patients "colonized or infected" with CRE, making clear these are separate clinical states 1. Rectal surveillance swabs are designed specifically to detect asymptomatic carriers who serve as reservoirs for transmission—not to diagnose clinical infection.

Understanding Colonization vs. Infection

Colonization means CRE is present in the gastrointestinal tract without causing disease. The evidence demonstrates this distinction clearly:

• During outbreak investigations, surveillance cultures identified colonized patients "who were not previously known to harbor CRKP and were not placed in contact precautions"—these patients had positive swabs but no clinical infection 1
• The goal of active surveillance is explicitly stated as identifying "undetected carriers" and "colonized patients," not infected patients 1
• Recent data show that among ICU patients with CRE-positive rectal swabs, only 48.7% subsequently developed actual CRE infections after a mean of 11.4 days 2

Risk of Progression from Colonization to Infection

While colonization does not equal infection, colonized patients face substantial risk of developing subsequent CRE infections:

• In ICU settings, approximately 33-49% of colonized patients progress to clinical infection 2, 3, 4
• The time from positive rectal swab to infection averages 11-17 days 2
• Independent risk factors for progression include: multiple hospitalizations (>3 times), coma, carbapenem exposure, mechanical ventilation, and prolonged ICU stay 2, 5, 4

Clinical Decision-Making Algorithm

When encountering a positive CRE rectal swab:

1. Assess for clinical signs of infection:

   • Fever, hemodynamic instability, elevated inflammatory markers
   • Source identification: pneumonia, urinary tract infection, bloodstream infection, surgical site infection
   • New or worsening organ dysfunction

2. If clinical infection is present:

   • Obtain appropriate cultures from the suspected infection site (blood, urine, respiratory, wound)
   • The rectal swab result should inform empirical antibiotic selection to cover CRE while awaiting site-specific cultures 3
   • De-escalate promptly based on culture results and clinical response 3

3. If no clinical infection is present:

   • The patient has colonization only—do not treat with antibiotics
   • Implement contact precautions to prevent transmission 1
   • Monitor closely for development of infection, especially if risk factors are present

Critical Pitfalls to Avoid

Do not treat colonization with antibiotics. This is perhaps the most important clinical error to avoid. Treating asymptomatic colonization:

• Provides no clinical benefit
• Increases antibiotic resistance pressure
• Exposes patients to unnecessary drug toxicity
• Wastes healthcare resources

The 82% concordance between rectal and clinical isolates means that when infection does occur, the colonizing organism is usually the culprit 2. This makes the rectal swab result valuable for guiding empirical therapy in a colonized patient who develops new sepsis—but only if clinical infection is actually present.

Infection Control Implications

Regardless of infection status, all patients with positive CRE rectal swabs require contact precautions 1. The 2009 CDC/HICPAC guidance is unequivocal: "All patients colonized or infected with CRE or carbapenemase-producing Enterobacteriaceae should be placed on contact precautions." Single-room isolation is preferred, with cohorting as an alternative when resources are limited 6.